RE: where are we27 Aug 2022 07:44
What about the development of a multiplex for aspergillus? More news since the 2021 announcement.
What about the development of a pcr in 10min as mentioned by Emma Stokes last year?
When are the single transplant assays coming out? Same for the viral and bacterial GI assays?
What about the advancement in the biosensor?
Are there other LFTs in development?
etc etc etc
The list is long, other questions may arise on DR. Unfortunately, the company once again chooses the fuzzy and the vague.
While they might not have much to say about signing new big deals, if there aren't any, they might tell us about other things, like the DR discussed above.
But they choose to maintain the mystery for a reason that escapes me once again.
Some will say, R&D is all well and good, but you still have to sell the products. What can I say, if not, yes, you are right.
They have to prove to us that they can do it, and they haven't done that yet...
It is difficult to predict their ability to succeed in the challenges they face. To say that she is doomed to go back to the bottom of AIM is not justified.
The possibilities still exist, although they seem, it cannot be denied, much more difficult and remote to reach.
Despite the deafening silence of the BoD, we manage to distinguish that it is working behind the scenes, fortunately moreover, with the readjustment of the number of employees, the internships for those remaining to improve their capacities, etc.
In any case, today, and as DRB was able to point out to us, novacyt values absolutely nothing. Worse than that, we can even consider its negative valuation! It's crazy though!
Have we reached the bottom for all that? I dare not even answer... The bottoms follow one another, and the New Year lows too.
Maintaining positivity is therefore all the more complicated. The BoD isn't doing much to help us find them either.
We will see what will result from all this, if the real investors will have been right to persist in keeping this action in their portfolio or not.
Saying all is lost is not the time, although it seems some would have us believe so. As said, the possibilities of a recovery exist, it is up to the BoD to realize them.
There are other things I could ***** about in this post, such as their salary increase, which is an insult to SH.
The negative about this company currently seems to outweigh the positive.
Hard to be otherwise.
However, there may also be positive things to come. this was the purpose of my message.
But all that to say, who will live will see.
Good luck to all in your personal choices on this title.
This is neither an invitation to buy or sell. AMF shareholder.
To the derampers who will come and attack me as usual, f**** you.
Translated from french with Google but doesnt looks too Bad.
Sign In
Follow the stocks
